Revenue for Q3FY25 of INR 5,586 Million, a growth of 19% (y-o-y); 9MFY25 revenue stood at INR 16,377 Million, a growth of 16% (y-o-y) EBITDA for Q3FY25 of INR 923 Million, a growth of 15% (y-o-y) with 16.5% Margins and PAT for Q3FY25 of INR 70
Revenue for Q3FY25 of INR 5,586 Million, a growth of 19% (y-o-y); 9MFY25 revenue stood at INR 16,377 Million, a growth of 16% (y-o-y) EBITDA for Q3FY25 of INR 923 Million, a growth of 15% (y-o-y) with 16.5% Margins and PAT for Q3FY25 of INR 70
Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient
Dr Nikhil Mehta, Consultant Surgical Oncologist, HCG Cancer Centre, Jaipur Colon cancer, traditionally considered a condition affecting older adults, has been increasingly diagnosed in younger individuals. According to the American Cancer Society, cases among adults under 50 have been steadily rising, making it critical for younger
Dr. Raghavendra Ramanjulu, Lead Consultant - Palliative Medicine & Rehabilitation, Aster CMI Hospital, Bangalore Pancreatic cancer, often dubbed the “silent killer,” is one of the deadliest forms of cancer due to its asymptomatic onset and rapid progression. Globally, it remains a significant cause of cancer-related deaths,
Dr. Kshitij Domadia, Consultant- Medical Oncology, HCG Cancer Centre, Ahmedabad Cancer treatment has undergone transformative advancements in recent years, fueled by research and innovative breakthroughs. These strides have unlocked new pathways for addressing complex diseases, offering patients more effective and personalized treatment options. As scientists continue
KIMS Cuddles, Kurnool Dr. Swetha Rampally, Pediatric Neurologist The human brain is incredibly delicate, and even the slightest change can lead to a variety of severe issues. It is quite uncommon for three children from different regions to experience the same neurological disorder simultaneously. However, this rare
Dr. Raghunath S.K, Senior Consultant and Director of Uro-oncology and Robotic Surgery HCG Cancer Centre, KR Road, Bangalore In the fight against kidney cacer, especially in its advanced stages, the advent of immunotherapy has brought new hope. Imagine your body's immune system as an army fighting invaders like germs.
ImPaCCT Foundation, Tata Memorial Centre, hosted a press conference today at the hospital, addressing crucial aspects of Paediatric Cancer Care in India. Speaking at the event were, Ms. Shalini Jatia (Officer-in-Charge, ImPaCCT Foundation, Tata Memorial Centre), Dr. Shripad Banavali (Director, Academics, Tata Memorial Centre) and Dr.
Dr. Somdipa Pal, Associate Consultant Paediatric Hemato-Oncology & BMT, Fortis Hospital, Bannerghatta Road Childhood cancer is a devastating reality, according to GLOBOCAN 2020, an estimated 400,000 children under the age of 15 are diagnosed with cancer each year worldwide. However, there's a glimmer of hope on
~ Amit Chopra, Managing Director, India & South Asia, Thermo Fisher Scientific The onset of monsoons in India provides relief from the intense heat, but it also brings a concurrent rise in allergies. Triggered by immunoglobulin E (IgE), an allergy is an exaggerated immune response, to